JP Morgan Maintains Overweight on Eli Lilly, Raises Price Target to $1400

Benzinga Newsdesk www.benzinga.com Positive 73.2%

Neg 0% Neu 0% Pos 73.2%

JP Morgan analyst Chris Schott maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1300 to $1400.